Research ExplorerPublicationsAdvancement of mesenchymal stem cell therapy in solid organ ...

Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT).

Standard

Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT). / Hoogduijn, Martin J; Popp, Felix C; Grohnert, Anja; Crop, Meindert J; van Rhijn, Marieke; Rowshani, Ajda T; Eggenhofer, Elke; Renner, Philipp; Reinders, Marlies E; Rabelink, Ton J; van der Laan, Luc J W; Dor, Frank J M F; Ijzermans, Jan N M; Genever, Paul G; Lange, Claudia; Durrbach, Antoine; Houtgraaf, Jaco H; Christ, Bruno; Seifert, Martina; Shagidulin, Murat; Donckier, Vincent; Deans, Robert; Ringden, Olle; Perico, Norberto; Remuzzi, Giuseppe; Bartholomew, Amelia; Schlitt, Hans J; Weimar, Willem; Baan, Carla C; Dahlke, Marc H; MISOT Study Group.

In: TRANSPLANTATION, Vol. 90, No. 2, 2, 2010, p. 124-126.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Hoogduijn, MJ, Popp, FC, Grohnert, A, Crop, MJ, van Rhijn, M, Rowshani, AT, Eggenhofer, E, Renner, P, Reinders, ME, Rabelink, TJ, van der Laan, LJW, Dor, FJMF, Ijzermans, JNM, Genever, PG, Lange, C, Durrbach, A, Houtgraaf, JH, Christ, B, Seifert, M, Shagidulin, M, Donckier, V, Deans, R, Ringden, O, Perico, N, Remuzzi, G, Bartholomew, A, Schlitt, HJ, Weimar, W, Baan, CC, Dahlke, MH & MISOT Study Group 2010, 'Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT).', TRANSPLANTATION, vol. 90, no. 2, 2, pp. 124-126. https://doi.org/10.1097/TP.0b013e3181ea4240

APA

Hoogduijn, M. J., Popp, F. C., Grohnert, A., Crop, M. J., van Rhijn, M., Rowshani, A. T., Eggenhofer, E., Renner, P., Reinders, M. E., Rabelink, T. J., van der Laan, L. J. W., Dor, F. J. M. F., Ijzermans, J. N. M., Genever, P. G., Lange, C., Durrbach, A., Houtgraaf, J. H., Christ, B., Seifert, M., ... MISOT Study Group (2010). Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT). TRANSPLANTATION, 90(2), 124-126. [2]. https://doi.org/10.1097/TP.0b013e3181ea4240

Vancouver

Hoogduijn MJ, Popp FC, Grohnert A, Crop MJ, van Rhijn M, Rowshani AT et al. Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT). TRANSPLANTATION. 2010;90(2):124-126. 2. https://doi.org/10.1097/TP.0b013e3181ea4240

Bibtex

@article{97e226a9c43a4037939509b94d4b5bd3,
title = "Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT).",
abstract = "There is evolving interest in the use of mesenchymal stem cells (MSC) in solid organ transplantation. Pre-clinical transplantation models show efficacy of MSC in prolonging graft survival and a number of clinical studies are planned or underway. At a recent meeting of the MISOT consortium (MSC In Solid Organ Transplantation) the advances of these studies were evaluated and mechanisms underlying the potential effects of MSC discussed. Continued discussion is required for definition of safety and eventually efficacy endpoints for MSC therapy in solid organ transplantation.",
keywords = "Humans, T-Lymphocytes immunology, Immunophenotyping, Immunosuppression methods, Cell Culture Techniques, Graft Survival physiology, Kidney Transplantation immunology, Liver Transplantation immunology, Mesenchymal Stem Cell Transplantation methods, Mesenchymal Stem Cells cytology, Organ Transplantation methods, Safety, Tissue Therapy methods, Humans, T-Lymphocytes immunology, Immunophenotyping, Immunosuppression methods, Cell Culture Techniques, Graft Survival physiology, Kidney Transplantation immunology, Liver Transplantation immunology, Mesenchymal Stem Cell Transplantation methods, Mesenchymal Stem Cells cytology, Organ Transplantation methods, Safety, Tissue Therapy methods",
author = "Hoogduijn, {Martin J} and Popp, {Felix C} and Anja Grohnert and Crop, {Meindert J} and {van Rhijn}, Marieke and Rowshani, {Ajda T} and Elke Eggenhofer and Philipp Renner and Reinders, {Marlies E} and Rabelink, {Ton J} and {van der Laan}, {Luc J W} and Dor, {Frank J M F} and Ijzermans, {Jan N M} and Genever, {Paul G} and Claudia Lange and Antoine Durrbach and Houtgraaf, {Jaco H} and Bruno Christ and Martina Seifert and Murat Shagidulin and Vincent Donckier and Robert Deans and Olle Ringden and Norberto Perico and Giuseppe Remuzzi and Amelia Bartholomew and Schlitt, {Hans J} and Willem Weimar and Baan, {Carla C} and Dahlke, {Marc H} and {MISOT Study Group}",
year = "2010",
doi = "10.1097/TP.0b013e3181ea4240",
language = "English",
volume = "90",
pages = "124--126",
journal = "TRANSPLANTATION",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

RIS

TY - JOUR

T1 - Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT).

AU - Hoogduijn, Martin J

AU - Popp, Felix C

AU - Grohnert, Anja

AU - Crop, Meindert J

AU - van Rhijn, Marieke

AU - Rowshani, Ajda T

AU - Eggenhofer, Elke

AU - Renner, Philipp

AU - Reinders, Marlies E

AU - Rabelink, Ton J

AU - van der Laan, Luc J W

AU - Dor, Frank J M F

AU - Ijzermans, Jan N M

AU - Genever, Paul G

AU - Lange, Claudia

AU - Durrbach, Antoine

AU - Houtgraaf, Jaco H

AU - Christ, Bruno

AU - Seifert, Martina

AU - Shagidulin, Murat

AU - Donckier, Vincent

AU - Deans, Robert

AU - Ringden, Olle

AU - Perico, Norberto

AU - Remuzzi, Giuseppe

AU - Bartholomew, Amelia

AU - Schlitt, Hans J

AU - Weimar, Willem

AU - Baan, Carla C

AU - Dahlke, Marc H

AU - MISOT Study Group

PY - 2010

Y1 - 2010

N2 - There is evolving interest in the use of mesenchymal stem cells (MSC) in solid organ transplantation. Pre-clinical transplantation models show efficacy of MSC in prolonging graft survival and a number of clinical studies are planned or underway. At a recent meeting of the MISOT consortium (MSC In Solid Organ Transplantation) the advances of these studies were evaluated and mechanisms underlying the potential effects of MSC discussed. Continued discussion is required for definition of safety and eventually efficacy endpoints for MSC therapy in solid organ transplantation.

AB - There is evolving interest in the use of mesenchymal stem cells (MSC) in solid organ transplantation. Pre-clinical transplantation models show efficacy of MSC in prolonging graft survival and a number of clinical studies are planned or underway. At a recent meeting of the MISOT consortium (MSC In Solid Organ Transplantation) the advances of these studies were evaluated and mechanisms underlying the potential effects of MSC discussed. Continued discussion is required for definition of safety and eventually efficacy endpoints for MSC therapy in solid organ transplantation.

KW - Humans

KW - T-Lymphocytes immunology

KW - Immunophenotyping

KW - Immunosuppression methods

KW - Cell Culture Techniques

KW - Graft Survival physiology

KW - Kidney Transplantation immunology

KW - Liver Transplantation immunology

KW - Mesenchymal Stem Cell Transplantation methods

KW - Mesenchymal Stem Cells cytology

KW - Organ Transplantation methods

KW - Safety

KW - Tissue Therapy methods

KW - Humans

KW - T-Lymphocytes immunology

KW - Immunophenotyping

KW - Immunosuppression methods

KW - Cell Culture Techniques

KW - Graft Survival physiology

KW - Kidney Transplantation immunology

KW - Liver Transplantation immunology

KW - Mesenchymal Stem Cell Transplantation methods

KW - Mesenchymal Stem Cells cytology

KW - Organ Transplantation methods

KW - Safety

KW - Tissue Therapy methods

U2 - 10.1097/TP.0b013e3181ea4240

DO - 10.1097/TP.0b013e3181ea4240

M3 - SCORING: Journal article

C2 - 20606604

VL - 90

SP - 124

EP - 126

JO - TRANSPLANTATION

JF - TRANSPLANTATION

SN - 0041-1337

IS - 2

M1 - 2

ER -